The proteomics of colorectal cancer

identification of a protein signature associated with prognosis

Donna O'Dwyer, Lynda D Ralton, Aisling O'Shea, Graeme I Murray

Research output: Contribution to journalArticle

66 Citations (Scopus)
3 Downloads (Pure)

Abstract

Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography–tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography–tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p<0.001), S100A9 (p<0.001) and translationally controlled tumour protein (p<0.001). Analysis of proteins individually identified 14-3-3ß as a prognostic biomarker (¿2 = 6.218, p = 0.013, HR = 0.639, 95%CI 0.448–0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3ß and aldehyde dehydrogenase 1 was identified as showing prognostic significance (¿2 = 7.306, p = 0.007, HR = 0.504, 95%CI 0.303–0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95%CI 0.208–0.829) in a multivariate model.
Original languageEnglish
Article numbere27718
Number of pages15
JournalPloS ONE
Volume6
Issue number11
DOIs
Publication statusPublished - 18 Nov 2011

Fingerprint

colorectal neoplasms
Proteomics
proteomics
prognosis
Colorectal Neoplasms
mucosa
Proteins
proteins
Mucous Membrane
protein synthesis
Cluster analysis
Biomarkers
biomarkers
cluster analysis
Mass spectrometry
Cluster Analysis
Mass Spectrometry
mass spectrometry
Gels
aldehyde dehydrogenase

Cite this

The proteomics of colorectal cancer : identification of a protein signature associated with prognosis. / O'Dwyer, Donna; Ralton, Lynda D; O'Shea, Aisling; Murray, Graeme I.

In: PloS ONE, Vol. 6, No. 11, e27718, 18.11.2011.

Research output: Contribution to journalArticle

@article{a0e312d214144e029c6f53e0ef2e19cb,
title = "The proteomics of colorectal cancer: identification of a protein signature associated with prognosis",
abstract = "Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography–tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography–tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p<0.001), S100A9 (p<0.001) and translationally controlled tumour protein (p<0.001). Analysis of proteins individually identified 14-3-3{\ss} as a prognostic biomarker (¿2 = 6.218, p = 0.013, HR = 0.639, 95{\%}CI 0.448–0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3{\ss} and aldehyde dehydrogenase 1 was identified as showing prognostic significance (¿2 = 7.306, p = 0.007, HR = 0.504, 95{\%}CI 0.303–0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95{\%}CI 0.208–0.829) in a multivariate model.",
author = "Donna O'Dwyer and Ralton, {Lynda D} and Aisling O'Shea and Murray, {Graeme I}",
year = "2011",
month = "11",
day = "18",
doi = "10.1371/journal.pone.0027718",
language = "English",
volume = "6",
journal = "PloS ONE",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY SCIENCE",
number = "11",

}

TY - JOUR

T1 - The proteomics of colorectal cancer

T2 - identification of a protein signature associated with prognosis

AU - O'Dwyer, Donna

AU - Ralton, Lynda D

AU - O'Shea, Aisling

AU - Murray, Graeme I

PY - 2011/11/18

Y1 - 2011/11/18

N2 - Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography–tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography–tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p<0.001), S100A9 (p<0.001) and translationally controlled tumour protein (p<0.001). Analysis of proteins individually identified 14-3-3ß as a prognostic biomarker (¿2 = 6.218, p = 0.013, HR = 0.639, 95%CI 0.448–0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3ß and aldehyde dehydrogenase 1 was identified as showing prognostic significance (¿2 = 7.306, p = 0.007, HR = 0.504, 95%CI 0.303–0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95%CI 0.208–0.829) in a multivariate model.

AB - Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography–tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography–tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p<0.001), S100A9 (p<0.001) and translationally controlled tumour protein (p<0.001). Analysis of proteins individually identified 14-3-3ß as a prognostic biomarker (¿2 = 6.218, p = 0.013, HR = 0.639, 95%CI 0.448–0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3ß and aldehyde dehydrogenase 1 was identified as showing prognostic significance (¿2 = 7.306, p = 0.007, HR = 0.504, 95%CI 0.303–0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95%CI 0.208–0.829) in a multivariate model.

U2 - 10.1371/journal.pone.0027718

DO - 10.1371/journal.pone.0027718

M3 - Article

VL - 6

JO - PloS ONE

JF - PloS ONE

SN - 1932-6203

IS - 11

M1 - e27718

ER -